Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Data Collection × Dermatologic × Clear all

Status

Unknown 1 Terminated 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 3 Gynecologic 2 Genitourinary 2 Thoracic 1 Other hematologic neoplasm 1 Gastrointestinal 1 Dermatologic 1

Conditions

Interventions

Nivolumab 23 pembrolizumab 18 Ipilimumab 14 Temozolomide 12 Cyclophosphamide 9 toripalimab 8 Blood Specimen Collection 8 Biopsy 8 camrelizumab 6 Imiquimod 6 Dacarbazine 6 trametinib 5 fludarabine 5 dabrafenib 5 atezolizumab 5 Cisplatin 5 Chemotherapy, Adjuvant 5 fludarabine phosphate 4 durvalumab 4 apatinib 4 aldesleukin 4 Sorafenib 4 Interleukin-2 4 Injections 4 Bevacizumab 4 Aminolevulinic Acid 4 palbociclib 3 methyl 5-aminolevulinate 3 binimetinib 3 Tomography, Optical Coherence 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05641012 2022-12-07

Helioma

Institut Jean-Godinot

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡